Lanthanum carbonate impacts on calcification regulating factors in chronic kidney disease

Trial Profile

Lanthanum carbonate impacts on calcification regulating factors in chronic kidney disease

Not yet recruiting
Phase of Trial: Phase IV

Latest Information Update: 19 Apr 2017

At a glance

  • Drugs Lanthanum carbonate (Primary) ; Calcium carbonate
  • Indications Renal failure
  • Focus Therapeutic Use
  • Acronyms MBD-CRF
  • Most Recent Events

    • 19 Apr 2017 Last checked against University Hospital Medical Information Network - Japan record.
    • 13 Apr 2017 Planned End Date changed from 30 Jun 2015 to 31 Dec 2018.
    • 24 Jul 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top